منوی اصلی

پروفایل استاد

دکتر سها - نمازی

مشاهده گروه
مرتبه علمی استادیار
رشته تحصیلی بالینی
سابقه فعالیت 0
فایل مورد نظر خود را جستجو کنید
ارسال پیغام جدید
مشاهده پیام نام استاد تاریخ ارسال وضعیت پیغام

A Case of Ciprofloxacin-Induced QT Prolongation and Torsade de Pointes
H Keshavarz-Bahaghighat, S Najafi, S Namazi, ZJ Rafsanjani
Journal of Pharmaceutical Care 4 (1-2), 46-49

2017

Impact of CYP2C19 polymorphisms on serum concentration of voriconazole in iranian hematological patients
S Ebrahimpour, S Namazi, M Mohammadi, M Nikbakht, M Hadjibabaie, ...
Journal of research in pharmacy practice 6 (3), 151

2017

Curcuminoids modify lipid profile in type 2 diabetes mellitus: A randomized controlled trial
Y Panahi, N Khalili, E Sahebi, S Namazi, Ž Reiner, M Majeed, A Sahbekar
Complementary Therapies in Medicine

2

2017

Association of ABCB1 Gene Polymorphisms and Clopidogrel Responsiveness in South Iranian Patients undergoing Percutaneous Coronary Intervention (Spring 20...
S Namazi, E Sahebi, N Azarpira, J Rostami-Yalmeh, J Kojuri, A Khalili
Iranian Journal of Pharmaceutical Research

2017

Effect of Demographic and Clinical Factors on New-Onset Diabetes Mellitus after Liver Transplantation in Iranian Patients
S Namazi, N Azarpira
Journal of Pharmaceutical Care 3 (3-4), 37-43

2017

CP-166 Impact of guideline implementation on albumin and intravenous pantoprazole expenditure in a referral teaching hospital, Tehran, Iran
ZJ Rafsanjani, H Kamyab, M Nosrati, S Najafi, H Keshavarz-Bahaghighat, ...
Eur J Hosp Pharm 24 (Suppl 1), A74-A75

2017

Association of ABCB1 (C3435T) and ABCC1 (G2012T) Polymorphisms with Clinical Response to Atorvastatin in Iranian Patients with Primary Hyperlipidemia
N Behdad, J Kojuri, N Azarpira, A Masoomi, S Namazi
Iranian biomedical journal 21 (2), 120

2017

Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial
Y Panahi, N Khalili, E Sahebi, S Namazi, MS Karimian, M Majeed, ...
Inflammopharmacology 25 (1), 25-31

15

2017

A comparison of five common drug–drug interaction software programs regarding accuracy and comprehensiveness
R Kheshti, M Aalipour, S Namazi
Journal of research in pharmacy practice 5 (4), 257

5

2016

Comparison of antiplatelet activity of garlic tablets with cardio-protective dose of aspirin in healthy volunteers: a randomized clinical trial
M Shafiekhani, P Faridi, J Kojuri, S Namazi
Avicenna journal of phytomedicine 6 (5), 550

2016

Health Care Workers’ Knowledge, Attitude, and Practice About Chronic Pain Management, Shiraz, Iran
R Kheshti, S Namazi, M Mehrabi, D Firouzabadi
Anesthesiology and pain medicine 6 (4)

1

2016

Association of Endothelial Nitric Oxide Synthase Gene Polymorphisms With Acute Rejection in Liver Transplant Recipients.
N Azarpira, S Namazi, S Malahi, K Kazemi
Experimental and clinical transplantation: official journal of the Middle …

1

2016

Usage pattern and serum level measurement of amikacin in the internal medicine ward of the largest referral hospital in the south of Iran: a pharmacoepidemiologica...
S Namazi, MM Sagheb, MM Hashempour
Iranian journal of medical sciences 41 (3), 191

1

2016

Knowledge, attitude and practice of General Practitioners towards adverse drug reaction reporting in South of Iran, Shiraz (Pharmacoepidemiology report)
P Peymani, R Tabrizi, S Afifi, S Namazi, ST Heydari, MK Shirazi, ...
International Journal of Risk & Safety in Medicine 28 (1), 25-31

2016

Phenytoin-Induced Gingival Over Growth: A Review
I Karimzadeh, S Namazi, A Borhani-Haghighi, H Khosropanah
Social Pharmacy Journal 1 (1)

2016

Monitoring of Thromboembolic Events Prophylaxis: Where Do We Stand?
L Mahmoudi, S Namazi, S Nemati, R Niknam
Journal of Hematology 4 (4), 223-227

2015

SCN1A and SCN1B gene polymorphisms and their association with plasma concentrations of carbamazepine and carbamazepine 10, 11 epoxide in Iranian epilepti...
S Namazi, N Azarpira, K Javidnia, M Emami, R Rahjoo, R Berahmand, ...
Iranian journal of basic medical sciences 18 (12), 1215

2

2015

Role of pharmacogenomics in Statin Responsiveness; A review
S Namazi
Trends in Pharmaceutical Sciences 1 (4), 183-190

2015

Effect of angiotensin receptor blockade on prevention and reversion of tamoxifen-resistant phenotype in MCF-7 cells
S Namazi, E Sahebi, J Rostami-Yalmeh, M Jaberipour, M Razmkhah, ...
Tumor Biology 36 (2), 893-900

4

2015

Incidence of potential drug-drug interaction and related factors in hospitalized neurological patients in two Iranian teaching hospitals
S Namazi, S Pourhatami, A Borhani-Haghighi, S Roosta
Iranian journal of medical sciences 39 (6), 515

4

2014

The role of captopril and losartan in prevention and regression of tamoxifen-induced resistance of breast cancer cell line MCF-7: an in vitro study
S Namazi, J Rostami-Yalmeh, E Sahebi, M Jaberipour, M Razmkhah, ...
Biomedicine & Pharmacotherapy 68 (5), 565-571

5

2014

The effect of metoprolol succinate on the cardiac function of patients with thalassaemia cardiomyopathy: a double-blind randomised study
J Kojury, A Zolghadrasli, M Karimi, MAB Beighi, S Namazi
Heart Asia 6 (1), 54-58

2014

Serum cystatin C as a marker of renal function in critically ill patients with normal serum creatinine
MM Sagheb, S Namazi, B Geramizadeh, A Karimzadeh, MB Oghazian, ...
Nephro-urology monthly 6 (2)

14

2014

Adverse drug reactions reporting: Pharmacists' knowledge, attitude and practice in Shiraz, Iran
S Afifi, N Maharloui, P Peymani, S Namazi, AG Gharaei, P Jahani, ...
International Journal of Risk & Safety in Medicine 26 (3), 139-145

7

2014

The impact of renin–angiotensin system, angiotensin І converting enzyme (insertion/deletion), and angiotensin ІІ type 1 receptor (A1166C) polymorphisms on breast...
S Namazi, A Daneshian, M Mohammadianpanah, P Jafari, ...
Gene 532 (1), 108-114

8

2013

Incidence of potential drug–/INS; drug interactions and its associated factors in neurology wards of two teaching hospitals in Shiraz, Iran
A Safari, S Namazi, S Pourhatami, AB Haghighi
Journal of the Neurological Sciences 333, e623-e624

2013

Lack of association of genetic polymorphisms of angiotensin converting enzyme 1 and angiotensin II type 1 receptor with breast cancer risk in Iranian population
S Namazi, A Monabati, S Ardeshir-Rouhani-Fard, N Azarpira
Tumor Biology 34 (5), 2899-2907

6

2013

The evaluation and management of drug-drug interactions in patients on cardiovascular and cardiosurgery wards in Namazi and Shahid Faghihi hospitals, Iran, Shir...
S Namazi, N Moosavi
Research in Pharmaceutical Sciences 7 (5), 911

2

2012

Evaluation of knowledge, attitudes, and practice of medical residents and nurses in Shiraz University of medical sciences regarding chronic pain management
S Namazi, R Kheshti, M Mehrabi
Research in Pharmaceutical Sciences 7 (5), 916

2012

A drug utilization evaluation of captopril in two coronary care unit wards of Namazi hospital, Shiraz, Iran
S Namazi, M Masjedi, N Zolfaghari
Research in Pharmaceutical Sciences 7 (5), 861

2012

Relation between body mass index and blood pressure in pediatrics, Shiraz
J Rostami, S Namazi, E Sahebi, B Fanni
Research in Pharmaceutical Sciences 7 (5), 905

2012

Audit of amikacin usage pattern in the internal medicine ward of Namazi hospital, Shiraz, Iran
S Namazi, M Sagheb, M Hashempoor
Research in Pharmaceutical Sciences 7 (5), 872

2012

The relation between ABCB1 (c3435t) gene polymorphism and clopidogrel resistance in Iranian patients under treatment with PCI
E Sahebi, S Namazi, J Rostami, N Azarpira, J Kojuri
Research in Pharmaceutical Sciences 7 (5), 405

2012

The Pattern of Platelet Response to Clopidogrel in Iranian Patients After Percutaneous Coronary Intervention
S Namazi, A Khalili, J Kojuri, N Azarpira
The Journal of Clinical Pharmacology 52 (7), 1098-1105

1

2012

Adverse reactions of immunosuppressive drugs in Iranian adult kidney transplant recipients.
S Namazi, MM Sagheb, I Karimzadeh
Experimental and clinical transplantation: official journal of the Middle …

2012

The impact of genetic polymorphisms of P2Y12, CYP3A5 and CYP2C19 on clopidogrel response variability in Iranian patients
S Namazi, J Kojuri, A Khalili, N Azarpira
Biochemical pharmacology 83 (7), 903-908

30

2012

The investigation of allele and genotype frequencies of CYP3A5 (1*/3*) and P2Y12 (T744C) in Iran
N Azarpira, S Namazi, A Khalili, M Tabesh
Molecular biology reports 38 (8), 4873-4877

10

2011

Influence of gene polymorphisms on clopidogrel responsiveness in Iranian patients after percutaneous coronary intervention (PCI)
S Namazi, J Kojuri, N Azarpira, A Khalili, E Sahebi, MJ Rostami
THERAPEUTIC DRUG MONITORING 33 (4), 508-509

2011

Association of gene polymorphisms and carbamazepine and carbamazepine10, 11 epoxide plasma level in epileptic Iranian patients
S Namazi, M Farshad, N Azarpira, BA Haghighi, K Javidnia, R Rahjoo, ...
THERAPEUTIC DRUG MONITORING 33 (4), 509-509

2011

The effect of renin angiotensin system on tamoxifen resistance
S Namazi, S Ardeshir-Rouhani-Fard, H Abedtash
Medical hypotheses 77 (1), 152-155

17

2011

Drug utilization evaluation of unfractionated heparin in a cardiac care unit in Iran
S Namazi, I Karimzadeh
J Pharm Res 4 (5), 1470-2

3

2011

Cardiovascular drug adverse reactions in hospitalized patients in cardiac care unit
I Karimzadeh, S Namazi, G Shalviri, K Gholami
African Journal of Pharmacy and Pharmacology 5 (4), 493-499

7

2011

Evaluating the effect of 3 glucocorticoid receptor gene polymorphisms on risk of relapse in 100 Iranian children with acute lymphoblastic leukemia: a case-control stu...
S Namazi, S Zareifar, A Monabati, S Ansari, I Karimzadeh
Clinical therapeutics 33 (3), 280-290

10

2011

Adverse reactions to antiepileptic drugs in epileptic outpatients: a cross-sectional study in Iran
S Namazi, A Borhani-Haghighi, I Karimzadeh
Clinical neuropharmacology 34 (2), 79-83

12

2011

ﻲﻓ ﻰرﺒﻜﻠا ﺔﻠاﺤإﻠا ﺖاﻴﻔﺸﺘﺴﻣ ﺪﺤأ ﻲﻓ ﺔﻴﺤارﺟ ﺔﻌاﻗ ﻲﻓ ﻲوﻴﺣ ﺪاﻀﻤﻟ ﻲﺌاﻘوﻠا ءاﻄﻌإﻠا ﻢﻴﻴﻘﺗ ﺔﻴﻤاﻠﺴإﻠا ﻦارﻴإ ﺔﻴروﻬﻤﺟ‎
G Vessal, S Namazi, MA Davarpanah, F Foroughinia
EMHJ 17 (8), 663-668

2011

تقييم الإعطاء الوقائي لمضاد حيوي في قاعة جراحية في أحد مستشفيات الإحالة الكبرى في جمهورية إيران الإسلامية‎
G Vessal, S Namazi, MA Davarpanah, F Foroughinia
EMHJ 17 (8), 663-668

2011

Evaluation of prophylactic antibiotic administration at the surgical ward of a major referral hospital, Islamic Republic of Iran
G Vessal, S Namazi, MA Davarpanah, F Foroughinia

25

2011

Association of angiotensin I converting enzyme (insertion/deletion) and angiotensin II type 1 receptor (A1166C) polymorphisms with breast cancer prognostic factors...
S Namazi, A Monabati, S Ardeshir‐Rouhani‐Fard, N Azarpira
Molecular carcinogenesis 49 (12), 1022-1030

26

2010

Investigation of allele and genotype frequencies of CYP2C9, CYP2C19 and VKORC1 in Iran
N Azarpira, S Namazi, F Hendijani, M Banan, M Darai
Pharmacological Reports 62 (4), 740-746

54

2010

The impact of genetic polymorphisms and patient characteristics on warfarin dose requirements: a cross-sectional study in Iran
S Namazi, N Azarpira, F Hendijani, MB Khorshid, G Vessal, ...
Clinical therapeutics 32 (6), 1050-1060

32

2010

A Drug Utilization Research on Aminophylline/Theophyl-line in Ali-Asghar Hospital, Shiraz, Southern Iran
S Namazi, V Gh, H Sh, MA Ostovan, Z Mehrpuor
Iranian Red Crescent Medical Journal 2010 (2), 181-186

2010

Long-term complications of sulphur mustard poisoning in intoxicated Iranian veterans
S Namazi, H Niknahad, H Razmkhah
Journal of medical toxicology 5 (4), 191-195

35

2009

Assessment of amikacin plasma level in a referral hospital in southern Iran
S Namazi, M Sagheb, G Vessal, M Hashempoor
Clinical Microbiology & Infection 15 (4), S579

2009

Erythropoietin as a Neuroprotectant: Does Phenytoin Exert its Neuroprotective Functions Through Stimulation of Erythropoietin Production?
I Karimzadeh, S Namazi, G Vessal
Hypotheses Res Med 5, 79-91

1

2009

Role of endothelin-1 in tamoxifen resistance: Mechanism for a new possible treatment strategy in breast cancer
S Namazi, SAR Fard, H Abedtash
Medical hypotheses 70 (1), 109-111

1

2008

AN INVESTIGATION INTO THE RELATIONSHIP BETWEEN PRINCIPALS'JOB MOTIVE AND JOB SATISFACTION AND ORGANIZATIONAL COMMITMENT OF MAR...
M Saatchi, N GHASEMI, S Namazi
QUARTERLY JOURNAL OF NEW APPROACH IN EDUCATIONAL ADMINISTRATION 1 (2), 153-174

2

2008

The neuroprotective effect of erythropoietin in prevention of neuropsychiatric manifestation of SLE
F Foroughinia, S Namazi
Medical hypotheses 68 (3), 708-709

2

2007

Is oral azithromycin effective for the treatment of phenytoin-induced gingival overgrowth in epileptic patients?
S Namazi, AB Haghighi, I Karimzadeh
Medical hypotheses 69 (5), 1159-1160

4

2007

Vancomycin use in a large teaching hospital in Shiraz, Islamic Republic of Iran, 2003
M Askarian, O Assadian, GR Safaee, A Golkar, S Namazi, MR Movahed
Eastern Mediterranean Health Journal 13 (5), 1195-1201

12

2007

Adherence to American Society of Health-System Pharmacists surgical antibiotic prophylaxis guidelines in Iran
M Askarian, AR Moraweji, H Mirkhani, S Namazi, H Weed
Infection Control & Hospital Epidemiology 27 (8), 876-878

42

2006

Case Presentation of a 45 Years Old Woman with Hypoglycemia and Bleeding
S Namazi, G Rozitalab
Iranian Journal of Pharmaceutical Sciences 1 (3), 183-188

2005

Division of the Caspian Sea: Iranian policies and concerns
S Namazi, F Farzin
The Caspian: Politics, energy and security, 230-243

5

2004

COMPARISON OF SERUM DIGOXIN LEVEL AND CLINICAL RESPONSE IN PATIENTS WITH CHRONIC ATRIAL FIBRILLATION IN TWO DIFFERENT WAYS OF CO...
E NEMATIPOUR, F SABOUR, S NAMAZI
IRANIAN HEART JOURNAL (IHJ) 4 (4), 63-67

2003

Assessment of Digoxin Serum Concentration in Continuous and Interrupted Digoxin Regimens.
S Sadray, S Namazi, K Gholami, M Eslami, M Lesanpezeshki, H Fani
DARU Journal of Pharmaceutical Sciences 11 (3), 99-105

3

2003

Section menu
G Vessal, A Khabiri, H Mirkhani, BD Cookson, M Askarian
Information for authors 1

1995

1389-1392

دکتری عمومی

دانشگاه تهران



100 %